Are oral contraceptives and diethylstilbestrol (tdes) involved in sex-linked cancer?
D000230:Adenocarcinoma / Q000139:chemically induced; D000818:Animals; D001943:Breast Neoplasms / Q000139:chemically induced; D003276:Contraceptives, Oral / Q000009:adverse effects*; D003281:Contraceptives, Postcoital / Q000009:adverse effects; D004054:Diethylstilbestrol / Q000009:adverse effects*; D004285:Dogs; D004347:Drug Interactions; D004967:Estrogens / Q000009:adverse effects; D005260:Female; D000882:Haplorhini; D006801:Humans; D008297:Male; D008325:Mammary Neoplasms, Experimental / Q000139:chemically induced; D051379:Mice; D009374:Neoplasms, Experimental / Q000139:chemically induced; D010911:Pituitary Neoplasms / Q000139:chemically induced; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy; D011372:Progestins / Q000009:adverse effects; D051381:Rats; D014565:Urogenital Neoplasms / Q000139:chemically induced*; D002583:Uterine Cervical Neoplasms / Q000139:chemically induced; D014625:Vaginal Neoplasms / Q000139:chemically induced
D003276:Contraceptives, Oral; D003281:Contraceptives, Postcoital; D004967:Estrogens; D011372:Progestins; D004054:Diethylstilbestrol